The DF/HCC SPORE in prostate cancer (Prostate SPORE) is focused on a wide range of initiatives. Among the current research projects listed below are studies to improve clinical decision-making about initiating hormone therapy for prostate cancer and preventing adverse effects in survivors, the use of gene expression patterns to discover genes and gene products linked to tumor development and progression, and the identification of molecular markers that can serve as prognostic indicators of prostate cancer.
Prostate Cancer SPORE Principal Investigator: Philip Kantoff, MD (DFCI)